|

"Seqirus Media Monitoring" 17th Aug 2017

News Highlights
CSL upbeat after 'exceptional' 2017 profit CSL flagged a further improvement in profits after an 'exceptional' 2016/17 result helped by stronger sales, and said Seqirus is expected to break even this year and is on track to profitability. Chief executive Paul Perreault said CSL's new products had strong market prospects.
Don't create policy, tax uncertainty: CSL's CEO Paul Perreault call to the Turnbull government CSL still has not made a return on its acquisition of Seqirus, but Paul Perreault said it had secured multiple new product licences. Seqirus has a seasonal flu vaccine, sales of which have remained steady, but could increase under a bad flu season in coming years as more people take flu vaccines
CSL shares fall as costs and Seqirus take toll on profits CSL Limited saw its shares fall over 5% to A$110.84 yesterday, after it reported its full-year 2016 results, showing that while sales were up profit declined due to due to one-off costs and losses incurred with the acquisition of the Novartis vaccine business.
CSL shares are getting hit as profit misses guidance CSL posted a net profit after tax of $US1.34 billion for the 2017 financial year, a rise of 7.4% from the year before. The profit missed analyst expectations though and a short time ago CSL shares were down
CSL chief Paul Perreault bewildered by stock fall CSL chief executive Paul Perreault has described the market’s negative reaction to the biotech’s jump in annual profit to $US1.3 billion ($1.66bn) as “typical”, arguing there are not many companies performing at his company’s level. CSL reported a 7.6 per cent lift in annual profit yesterday but its shares fell more than 6 per cent not long after the market opened, with some analysts claiming the numbers and 2018 guidance were slightly below expectations. “We come out with a great result and we have a double-digit outlook for the following year and people get disappointed. It’s hard for me to understand, to be honest,” Mr Perreault said.
Why CSL shares always fall no matter how good its results Apart from the organic growth CSL is achieving from the successful launches of new specialty products, there is latent growth potential in the two strategic acquisitions it has made under Perreault: last year Seqirus lost $US206m. While CSL didn’t break out the business’ losses for last financial year, it did say it lifted sales 23 per cent, that it was making good progress and was on track to break even this financial year
Philippine troops deployed to battle bird flu outbreak The Philippines will deploy hundreds of troops to hasten a cull of about 600,000 fowl, the farm minister said yesterday, as part of efforts to rein in the nation's first outbreak of bird flu
Patent expiry of Lyrica, Tamiflu heats up generic market In Korea, Tamiflu’s patent is about to expire, heralding a marketing war between the original and generics, and helping ensure a smoother supply of the drug as the country often experienced Tamiflu shortages
Flu vaccine less effective in obese individuals Not only is obesity a risk factor for flu complications, but it might actually make the flu vaccine less effective, says a study published by the International Journal of Obesity
Probe in Hong Kong over expired flu vaccines for patients An investigation has been launched by the Department of Health after a private doctor in Hong Kong gave expired FluQuadri vaccines to patients
Seqirus
CSL upbeat after 'exceptional' 2017 profit
CSL flagged a further improvement in profits after an 'exceptional' 2016/17 result helped by stronger sales, and said Seqirus is expected to break even this year and is on track to profitability. Chief executive Paul Perreault said CSL's new products had strong market prospects.
Why CSL shares always fall no matter how good its results
Apart from the organic growth CSL is achieving from the successful launches of new specialty products, there is latent growth potential in the two strategic acquisitions it has made under Perreault: last year Seqirus lost $US206m. While CSL didn’t break out the business’ losses for last financial year, it did say it lifted sales 23 per cent, that it was making good progress and was on track to break even this financial year
CSL chief Paul Perreault bewildered by stock fall
CSL chief executive Paul Perreault has described the market’s negative reaction to the biotech’s jump in annual profit to $US1.3 billion ($1.66bn) as “typical”, arguing there are not many companies performing at his company’s level. CSL reported a 7.6 per cent lift in annual profit yesterday but its shares fell more than 6 per cent not long after the market opened, with some analysts claiming the numbers and 2018 guidance were slightly below expectations. “We come out with a great result and we have a double-digit outlook for the following year and people get disappointed. It’s hard for me to understand, to be honest,” Mr Perreault said.
Don't create policy, tax uncertainty: CSL's CEO Paul Perreault call to the Turnbull government
CSL still has not made a return on its acquisition of Seqirus, but Paul Perreault said it had secured multiple new product licences. Seqirus has a seasonal flu vaccine, sales of which have remained steady, but could increase under a bad flu season in coming years as more people take flu vaccines
CSL shares fall as costs and Seqirus take toll on profits
CSL Limited saw its shares fall over 5% to A$110.84 yesterday, after it reported its full-year 2016 results, showing that while sales were up profit declined due to due to one-off costs and losses incurred with the acquisition of the Novartis vaccine business.
CSL expands to meet 'precious' plasma boom
Vaccines and blood products giant CSL is setting itself for a global upsurge in demand for "precious" plasma as it furthers a significant expansion of its plasma collection centres. CSL chief executive Paul Perreault says the company now has around 180 plasma collection centres in the US and Europe after opening 28 new locations over 2016/17, and plans to open another 25 to 30 in 2017/18.
CSL shares are getting hit as profit misses guidance
CSL posted a net profit after tax of $US1.34 billion for the 2017 financial year, a rise of 7.4% from the year before. The profit missed analyst expectations though and a short time ago CSL shares were down
CSL Full Year Result: Bumper 2017 result but 2018 forecast underwhelms investors
CSL is delivering on its influenza strategy and the unit is now on track to be a profitable business with shipping commenced for more than 50 million doses to the US. CSL said it expects to record a net profit after tax increase of 18% to 20% on a constant currency basis in FY18.
Pandemic Influenza News
2 people with flu-like symptoms test negative for bird flu
In the Philippines, two persons with flu-like symptoms who may have been exposed to chickens hit by the avian flu have tested negative for the virus, an official said
Philippine troops deployed to battle bird flu outbreak
The Philippines will deploy hundreds of troops to hasten a cull of about 600,000 fowl, the farm minister said yesterday, as part of efforts to rein in the nation's first outbreak of bird flu
Industry News
Patent expiry of Lyrica, Tamiflu heats up generic market
In Korea, Tamiflu’s patent is about to expire, heralding a marketing war between the original and generics, and helping ensure a smoother supply of the drug as the country often experienced Tamiflu shortages
ECDC experts confirm support for neuraminidase inhibitors
An expert panel from the European Center for Disease Prevention and Control reaffirmed that there is clear evidence to support using neuraminidase inhibitors to treat and prevent flu
Hetero to supply swine flu drug to Gujarat govt to avert any possibility of stock outs in near future
Hetero Healthcare, the first pharma company in India to launch anti-H1N1 drug oseltamivir in retail market under the brand name Fluvir, will be supplying 14,000 bottles of oseltamivir syrup to replenish the stocks in the state of Gujarat
Pig-to-person spread of flu at fairs a continued concern
The spread of influenza among pigs is common at fairs and other gatherings, and protective measures including cutting the length of time pigs and people congregate make good sense for both the animals and humans, say the authors of a new study
Flu vaccine less effective in obese individuals
Not only is obesity a risk factor for flu complications, but it might actually make the flu vaccine less effective, says a study published by the International Journal of Obesity
State touts access to child vaccines at pharmacies
In Massachusetts, for the first time, children ages 9 and up can get their flu vaccines at a pharmacy instead of from a primary care doctor, a change that officials say will make the vaccination process easier and more convenient for families
Report: Middle school vaccine mandates work
The CDC recommends that children receive vaccinations against meningococcal infections, HPV and seasonal influenza before entering middle school, but state mandates for these vaccinations vary; a report found no evidence that Tdap mandates had any effect on uptake of the seasonal flu vaccine
Live Attenuated Influenza Vaccine Ineffective in 2015-2016 Season
Overall, flu vaccines reduced the number of influenza illnesses in the 2015-2016 season, but the live attenuated influenza vaccine (LAIV) was shown to be ineffective in children during this time
Over 65’s influenza news

No News Recorded

General Influenza News
Doctors call for free flu shots as confirmed cases rise to 860 this year
As cases of influenza continue to rise in Tasmania, the peak body for GPs has called for free flu vaccinations across the community
CVS Health Survey Reveals Two in Three Americans who plan to get a Flu Shot Believe it is the Best Way to Prevent the Flu
Convenience (37%), doctor recommendations (36%) and insurance acceptance (35%) rank as top three determining factors on where Americans get their flu shot
Probe in Hong Kong over expired flu vaccines for patients
An investigation has been launched by the Department of Health after a private doctor in Hong Kong gave expired FluQuadri vaccines to patients
People not immune to flu striking twice
Australians are being warned that they may be hit with the flu twice this year, as a mix of influenza strains circulate the country, and that they should get vaccinated against four strains in one shot
Not just for kids: How practices can encourage adult patients to get vaccinations
Adults need to keep vaccinations up to date because immunity from childhood vaccines can wear off over time and adults are at risk for different diseases, including influenza, the CDC warned
Education and outreach crucial to teen vaccinate uptake
Like adults, less than half of adolescents receive the flu vaccine, and only Tdap vaccination meet the goals set forth in the federal HealthyPeople 2020 initiative with 80% compliance—due in part to state mandates for middle school entry
Burden of disease
First variant influenza case reported in ND
The North Dakota Department of Health reports a confirmed case of variant influenza A H3N2v in a child with exposure to pigs
Sick days and influenza admissions going through the roof in Taranaki
Admissions to hospital for influenza have skyrocketed and schools are seeing a surge in student absences in Taranaki, New Zealand
'Worst ever' flu season continues
In Australia, Northern NSW is in the grip of its worst flu season in at least 17 years and emergency departments across the region are under intense pressure to cope
Gujarat registers 1,883 swine flu cases since Jan
Gujarat registered 1,883 positive cases for H1N1 so far since January 2017. The death toll due to the disease has reached 208 so far during this period, the state government informed
1 dies, over 300 others taken ill due to seasonal influenza in Gorkha
In Nepal, a child has died and over 300 persons have taken ill due to seasonal influenza in Barkar of Gorkha district, the epicentre of Gorkha earthquake
Hong Kong's influenza activity continues to drop in past month: health department
The local seasonal influenza activity in Hong Kong continued to drop in the past month, the Health Department of the Hong Kong Special Administrative Region government reported
Death toll from seasonal influenza reaches 25 in Myanmar
The death toll from seasonal influenza A/H1N1-2009 reached 25 in Myanmar since the outbreak of the disease in July